Literature DB >> 6971902

Characterization of macrophage subpopulations responsive to activation by endotoxin and lymphokines.

K C Lee, M Wong, D McIntyre.   

Abstract

The subpopulations of murine macrophages (M phi) that can be activated by endotoxin (LPS) and lymphokines to produce lymphocyte-activating factor, or interleukin 1 (IL-1), and to express cytostatic and cytolytic activities against tumor cells were characterized in 3 cell populations with immature and mature M phi in various proportions, namely, normal peritoneal cells, glycogen-induced peritoneal cells, and cultured bone marrow M phi. There is disagreement in the literature as to whether tumor cytotoxicity can be elicited from all M phi or from a subset of small, newly formed peroxidase-positive (p+) monocytes. Using the technique of cell size fractionation, which separates p+ and p- M phi to various extents, we have found that the magnitude of te response to LPS and lymphokines increases with cell size (and hence maturity or the degree of prior stimulation) and is not exclusive to p+ M phi. Our results are consistent with the concept that all M phi, irrespective of developmental stage, can exist in a continuum of activated states, depending on the nature of the activation signals.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6971902

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Macrophages and antitumor reactions.

Authors:  W Den Otter; H F Dullens; R A De Weger
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  An in vitro system to study listericidal capacity of macrophages from separate mice: resident macrophages exhibit different activation patterns.

Authors:  D Ottendorfer; D Bitter-Suermann; U Hadding
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

3.  Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is inhibited by both prostaglandin E2 and nordihydroguaiaretic acid, a lipoxygenase inhibitor.

Authors:  G R Elliott; C Tak; C Pellens; S Ben-Efraim; I L Bonta
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Effects of acute administration of O,O,S-trimethyl phosphorothioate on the respiratory burst and phagocytic activity of splenic and peritoneal leukocytes.

Authors:  K E Rodgers; D D Ellefson
Journal:  Agents Actions       Date:  1988-06

5.  Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.

Authors:  I Sugawara; K C Lee; M Wong
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Endogenous peroxidase activity as a marker of macrophage renewal during BCG-induced inflammation in the rat lung.

Authors:  M L Warnock; M Sniezek; J Shellito
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

7.  Fate of Listeria monocytogenes in murine peritoneal macrophage subpopulations.

Authors:  L Harrington-Fowler; M S Wilder
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

8.  Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1.

Authors:  M D Wewers; S I Rennard; A J Hance; P B Bitterman; R G Crystal
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

9.  Differential activation of resident macrophage subsets with two sources of lymphokine preparations.

Authors:  D R Tabor; P H Saluk
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

Review 10.  Evidence of Biomass Smoke Exposure as a Causative Factor for the Development of COPD.

Authors:  Sarah J Capistrano; David van Reyk; Hui Chen; Brian G Oliver
Journal:  Toxics       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.